MenHibrix
-
Most prescribed diabetes drug may slow prostate, other cancers
- Apr 3, 2012
-
FDA finally approves Surfaxin®
- Mar 15, 2012
-
EKOS Corporation addresses treatment for pulmonary embolism
- May 3, 2012
-
Johnson & Johnson ignored FDA demand
- Jun 27, 2012
-
Popular MS treatment may not prevent disability
- Jul 19, 2012
-
Many Americans accidentally overdosing on over-the-counter pain pills
- Jun 4, 2012
-
FDA issues warning after codeine kills children post-surgery
- Aug 16, 2012
-
Artificial retina gives sight to blind mice
- Aug 16, 2012
-
Lucentis approved for diabetic macular edema
- Aug 14, 2012
-
Mayo Clinic: Patients in the dark about prescriptions
- Aug 9, 2012
-
Hospital's plan to prevent painkiller abuse
- Aug 8, 2012
-
Alzheimer's drug disappoints
- Aug 8, 2012
bladder cancer blood thinners Avandia Johnson & Johnson listeria Eliquis Nexavar generic Pradaxa Technology femur fractures Actos breast cancer Xarelto lorcaserin Zimmer lawsuits metal on metal hip replacement Fosamax FDA stroke pulmonary embolism meningitis Urban Travel metal-on-metal hip replacement diet drug liver damage venous thromboembolism EMA